TY - JOUR
T1 - Preventive and Therapeutic Effects of Silybum marianum Seed Extract Rich in Silydianin and Silychristin in a Rat Model of Metabolic Syndrome
AU - Awla, Naza Jalal
AU - Naqishbandi, Alaadin M.
AU - Baqi, Younis
N1 - © 2023 American Chemical Society.
PY - 2023/11/10
Y1 - 2023/11/10
N2 - Metabolic syndrome (MetS) has become an increasing global health problem, which leads to cardiovascular diseases and type 2 diabetes. Silybum marianum extracts have been reported to possess several biological activities. In this study, an ethyl acetate extract prepared from S. marianum seeds of the Iraqi Kurdistan region was analyzed to identify its chemical constituents. Subsequently, its potential for the prevention and treatment of MetS was studied in a rat model induced by a high-fat/high-fructose diet (HFD/F). Silydianin and silychristin were the most abundant flavonolignan constituents (39.4%) identified in the S. marianum extract (SMEE). HFD/F-induced rats treated with SMEE exhibited preventive effects including reduced serum triglyceride levels (TG), decreased glucose levels in an oral glucose tolerance test (p < 0.001), attenuated weight gain, and reduced blood pressure compared to the untreated control group. Therapeutic application of SMEE after inducing MetS led to lowering of TG (p < 0.001) and g
AB - Metabolic syndrome (MetS) has become an increasing global health problem, which leads to cardiovascular diseases and type 2 diabetes. Silybum marianum extracts have been reported to possess several biological activities. In this study, an ethyl acetate extract prepared from S. marianum seeds of the Iraqi Kurdistan region was analyzed to identify its chemical constituents. Subsequently, its potential for the prevention and treatment of MetS was studied in a rat model induced by a high-fat/high-fructose diet (HFD/F). Silydianin and silychristin were the most abundant flavonolignan constituents (39.4%) identified in the S. marianum extract (SMEE). HFD/F-induced rats treated with SMEE exhibited preventive effects including reduced serum triglyceride levels (TG), decreased glucose levels in an oral glucose tolerance test (p < 0.001), attenuated weight gain, and reduced blood pressure compared to the untreated control group. Therapeutic application of SMEE after inducing MetS led to lowering of TG (p < 0.001) and g
KW - flavonolignans
KW - metabolic syndrome
KW - prevention
KW - rat model
KW - Silybum marianum
KW - therapeutic
UR - http://www.scopus.com/inward/record.url?scp=85177768641&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85177768641&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/d47dc000-03ab-307e-9eb1-a44ff96765ce/
U2 - 10.1021/acsptsci.3c00171
DO - 10.1021/acsptsci.3c00171
M3 - Article
C2 - 37974616
AN - SCOPUS:85177768641
SN - 2575-9108
VL - 6
SP - 1715
EP - 1723
JO - ACS Pharmacology and Translational Science
JF - ACS Pharmacology and Translational Science
IS - 11
ER -